Close Window

Digital Look Email A Friend

Johnson & Johnson beefs up oncology pipeline with $3bn Halda acquisition

Published by Benjamin Chiou on 17th November 2025

(Sharecast News) - American pharma and medical giant Johnson & Johnson has announced the $3.05bn acquisition of clinical-stage biotech company Halda Therapeutics in hopes that the company can revolutionise the treatment of cancer.

URL: http://www.digitallook.com/dl/news/story/35500620/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.